The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Spencer David M. since 2015.
The trader's CIK number is 1627362.
At the time of the last reporting, Spencer David M. was the Chief Scientific Officer of Bellicum Pharmaceuticals, Inc. (stock ticker symbol BLCM).
Also see all insider trading activities at Bellicum Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | BLCM | 0 | $0 | 0 | $0 | 4,062 | $0 |
| 2018 | BLCM | 0 | $0 | 50,000 | $375,530 | 1,563 | $0 |
| 2017 | BLCM | 0 | $0 | 10,000 | $115,399 | 0 | $0 |
| 2016 | BLCM | 0 | $0 | 40,000 | $748,041 | 0 | $0 |
| 2015 | BLCM | 0 | $0 | 30,000 | $675,900 | 30,000 | $76,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-01-02 | BLCM | Option Ex | 2,500 | .00 | 0 |
| 2019-01-03 | BLCM | Option Ex | 1,562 | .00 | 0 |
| 2018-09-04 | BLCM | Sale | 10,000 | 7.04 | 70,410 |
| 2018-07-18 | BLCM | Sale | 40,000 | 7.63 | 305,120 |
| 2018-01-03 | BLCM | Option Ex | 1,563 | .00 | 0 |
| 2017-07-10 | BLCM | Sale | 10,000 | 11.54 | 115,399 |
| 2016-12-05 | BLCM | Sale | 5,000 | 20.00 | 100,000 |
| 2016-12-05 | BLCM | Sale | 5,000 | 20.00 | 100,000 |
| 2016-09-21 | BLCM | Sale | 300 | 20.04 | 6,012 |
| 2016-09-22 | BLCM | Sale | 10,000 | 19.68 | 196,830 |
| 2016-09-23 | BLCM | Sale | 6,200 | 20.19 | 125,171 |
| 2016-09-19 | BLCM | Sale | 700 | 20.02 | 14,013 |
| 2016-09-20 | BLCM | Sale | 100 | 20.00 | 2,000 |
| 2016-09-16 | BLCM | Sale | 1,700 | 20.01 | 34,015 |
| 2016-08-15 | BLCM | Sale | 1,000 | 20.00 | 20,000 |
| 2016-07-27 | BLCM | Sale | 10,000 | 15.00 | 150,000 |
| 2015-12-14 | BLCM | Option Ex | 5,000 | 2.55 | 12,750 |
| 2015-12-01 | BLCM | Sale | 5,000 | 22.95 | 114,740 |
| 2015-09-21 | BLCM | Option Ex | 5,000 | 2.55 | 12,750 |
| 2015-09-11 | BLCM | Sale | 5,000 | 19.00 | 95,000 |
| 2015-07-02 | BLCM | Option Ex | 20,000 | 2.55 | 51,000 |
| 2015-06-16 | BLCM | Sale | 20,000 | 23.31 | 466,160 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Spencer David M. (Chief Scientific Officer of Bellicum Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.